The First Modified Delphi Consensus Statement for Resuming Bariatric and Metabolic Surgery in the COVID-19 Times.
Bariatric surgery
COVID-19
Obesity surgery
Resuming elective surgery
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
22
06
2020
accepted:
28
07
2020
revised:
20
07
2020
pubmed:
3
8
2020
medline:
23
1
2021
entrez:
3
8
2020
Statut:
ppublish
Résumé
The purpose of this study was to achieve consensus amongst a global panel of expert bariatric surgeons on various aspects of resuming Bariatric and Metabolic Surgery (BMS) during the Coronavirus Disease-2019 (COVID-19) pandemic. A modified Delphi consensus-building protocol was used to build consensus amongst 44 globally recognised bariatric surgeons. The experts were asked to either agree or disagree with 111 statements they collectively proposed over two separate rounds. An agreement amongst ≥ 70.0% of experts was construed as consensus as per the predetermined methodology. We present here 38 of our key recommendations. This first global consensus statement on the resumption of BMS can provide a framework for multidisciplinary BMS teams planning to resume local services as well as guide future research in this area.
Identifiants
pubmed: 32740826
doi: 10.1007/s11695-020-04883-9
pii: 10.1007/s11695-020-04883-9
pmc: PMC7395568
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
451-456Références
Obes Surg. 2020 Oct;30(10):4159-4164
pubmed: 32458364
Obes Surg. 2020 Jun;30(6):2071-2073
pubmed: 32291701
Surg Endosc. 2020 Apr;34(4):1648-1657
pubmed: 31218425
Lancet Diabetes Endocrinol. 2020 Jul;8(7):640-648
pubmed: 32386567
Lancet Diabetes Endocrinol. 2020 May;8(5):447-455
pubmed: 32333880
Obes Surg. 2018 Feb;28(2):303-312
pubmed: 29243145
Lancet Diabetes Endocrinol. 2017 May;5(5):377-390
pubmed: 28126459
Obes Surg. 2020 Aug;30(8):3222-3223
pubmed: 32388706